Omega-3 fatty acid formulations in cardiovascular disease: dietary supplements are not substitutes for prescription products

“Fish oil is fish oil” is a convenient belief, and this review sets out to dismantle it — specifically the idea that an over-the-counter supplement can stand in for a prescription omega-3.

The argument runs on two tracks. Efficacy: purified EPA prescription products lower triglycerides without raising LDL cholesterol, an advantage not shared by all formulations. Quality: dietary supplements aren’t held to drug-grade manufacturing standards, so their actual content can vary, and some carry oxidized or unwanted components. For a patient using omega-3s to manage cardiovascular risk, those differences aren’t academic.

The practical takeaway is direct: when omega-3 therapy is the goal, use the FDA-approved prescription product, not a supplement. The resistance is commercial — a large supplement industry with financial stakes and far lighter regulatory scrutiny.

We rate the evidence moderate: a well-referenced narrative review (93 citations) from a credentialed cardiologist with no specific product ties disclosed, but no original data. Its clinical significance is moderate and practical — useful guidance given how many people take omega-3s — though the distinction it draws is one of product selection rather than a change in who should be treated.